ResearcherUniversity of MilanActive in the last 2 years

Chiara Borsari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4688-8362; OpenAlex author ID A5035521326. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. Last author DOI 10.1021/acs.jmedchem.6c00235 ↗
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells. Co-author DOI 10.1016/j.ejmech.2023.115286 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Raffaella Pacchiana · 2 shared papers, 2023–2026 · strength 0.41
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235 ↗
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Paola Conti · 2 shared papers, 2023–2026 · strength 0.41
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235 ↗
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Massimo Donadelli · 2 shared papers, 2023–2026 · strength 0.41
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235 ↗
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Adriana Celesia · 1 shared paper, 2026 · strength 0.23
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235 ↗
Alessandra Fiore · 1 shared paper, 2026 · strength 0.23
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235 ↗
Andrea Galbiati · 1 shared paper, 2023 · strength 0.18
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.